World's First Gonorrhoea Vaccine Rolled Out in England

England Launches World's First Gonorrhoea Vaccine England is at the forefront of a fight against rising gonorrhoea rates with the launch of the world's first gonorrhoea vaccine. The vaccine, while not a complete solution (only 30-40% effective), is a crucial step in tackling this sexually transmitted infection. The initiative primarily targets gay and bisexual men with a history of multiple partners or STIs, a demographic disproportionately affected by gonorrhoea. The high effectiveness of antibiotics is decreasing, making the vaccine even more important. The high number of cases (185,000 in 2023) and the vaccine's potential to reduce infections by 100,000 cases highlight the significance of this development. This preventative measure offers hope in the ongoing battle against this increasingly drug-resistant infection.